A new experimental drug may help restore cardiac function after heart failure, based on the results of its first human trial. Heart failure is among the leading causes of death worldwide. A significant portion of heart failure patients do not sufficiently respond to current medical therapy. Researchers in the US examined the safety and efficacy of the drug cimaglermin, which acts as a growth factor for the heart, helping the heart to repair itself following injury.<br/><br/>